We hear a lot from pharma about patient-centricity these days, and rightly so. But there are many ways of putting this important principle into practice, and they don’t have to be complicated or expensive.
Recently, we spoke to members of the IBD Registry Industry Working Group about what they’ve achieved in their first year, and whether or not it’s been worthwhile. It’s a very simple idea: the Registry executive team has clinical and academic expertise aplenty, industry colleagues contribute insights on how best to engage with pharma, and business development strategies to accelerate Registry participation.
The group’s activities have been fruitful, but perhaps more interesting still are the reflections on the experience. Members are proud of the way that companies have set aside commercial rivalries in order to support clinicians and patients, and the Registry chair concluded: “My message to pharma is, more of the same please!”
Stuart Bloom, Richard Gardner and Jeremy Thorpe on the Industry Working Group and ongoing collaboration with the NHS.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.